Co-sponsored CME/CE

Cardiac Co-Morbidity Board (Module 3 of 3): Tyrosine Kinase Inhibitor Toxicities

Faculty: Gary Hudes, MD; Ming Hui Chen, MD

Cosponsored by the American Society of Clinical Oncology^® and the American College of Cardiology Foundation.

Acute Coronary Syndrome: Options for Primary & Secondary Prevention 

Faculty: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI; Christopher P. Cannon, MD; E. Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI

Cosponsored by Vindico Medical Education and the American College of Cardiology Foundation; supported by an educational grant from Merck & Co., Inc.

Clarifying Oral Antiplatelet Therapy: A Straightforward Approach for Today's Practitioners 

Faculty: Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI; Matthew J. Price, MD, FACC, FSCAI

Jointly sponsored by Potomac Center for Medical Education and Rockpointe Corporation; supported by an independent medical education grant from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Cardiac Co-Morbidity Board (Module 2 of 3): VEGF Signaling Pathway Inhibitor Toxicities 

 Faculty: Kathy Miller, MD; Daniel J. Lenihan, MD, FACC

Cosponsored by the American Society of Clinical Oncology® and the American College of Cardiology Foundation.

Cardiac Co-Morbidity Board (Module 1 of 3): Trastuzumab/Anthracycline Toxicities 

Faculty: Michael Ewer, MD, JD; Charles E. Geyer, MD

Cosponsored by the American Society of Clinical Oncology^® and the American College of Cardiology Foundation.

Evidence and Intervention: Post-MI Choices for Optimal Patient Outcomes 

Faculty: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC; Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI

Jointly sponsored by the Postgraduate Institute for Medicine and ACCELMED; supported by educational grants from Daiichi Sankyo, Inc. and Lilly USA, LLC, and Accumetrics, Inc.

Current and Emerging Strategies in Antiplatelet Therapy for Acute Coronary Syndrome: A CME Evidence-Based Best Practices Program™ 

Faculty: Jeffrey L. Anderson, MD, MACP, FACC, FAHA; Peter Berger, MD, FACC, FAHA; Stephen D. Wiviott, MD, FACC

Cosponsored by the American College of Cardiology Foundation, Albert Einstein College of Medicine and Montefiore Medical Center, and Asante Communications, LLC; supported by educational grants from Daiichi Sankyo, Inc., and Lilly USA, LLC.

Contemporary Issues in Hypertension: Today’s Controversy and Consensus 

Faculty: Shawna D. Nesbitt, MD, MS; Franz H. Messerli, MD, FACC, FACP

Cosponsored by the American Society of Hypertension, Inc.; TCL Institute, LLC; and the American College of Cardiology Foundation; supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

Optimizing Approaches to Pulmonary Arterial Hypertension Diagnosis and Management 

Faculty: Richard Channick, MD; Victor Tapson, MD; Kelly McCoy; Vallerie V. McLaughlin, MD

Cosponsored by the University of Michigan Medical School, TCL Institute, LLC and the American College of Cardiology Foundation; supported by an educational grant from Gilead.

CardioSource Co-sponsored CME/CE is provided in the American College of Cardiology Foundation (ACCF) online environment as a service to ACC members and other healthcare professionals, to promote understanding of the important scientific and clinical issues presented. This program does not constitute an endorsement or recommendation of any product, company or service related to a specific educational activity.

As a co-sponsor, ACCF supports the content validity and fair balance through a robust peer review process; however, these activities are certified for CME/CE credit, planned, and implemented by education Providers external to the ACCF.

For any questions regarding the content of this presentation, or records of your participation, please contact the accredited provider.